Financial Ratios Molina Healthcare, Inc.

Equities

MOH

US60855R1005

Managed Healthcare

Market Closed - Nyse Other stock markets 21:00:02 13/04/2026 BST			After hours 22:42:25
149.98 ^USD	+2.81%		148.38	-1.07%

04-07	The Market's Nerves of Steel
04-07	Health insurers rise after US lifts 2027 Medicare Advantage payment rates	RE

96f213a.RvF8nKOt7AA0vYUCXqM6qozadvgxzGh4eZy1Xdm774c.Bbc49cz7pW1F_tRhC_AI7tqDNMhSqyBLHKTdL5LsqfALpTOs05WhUVrF6g

Published financial data: MOLINA HEALTHCARE, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Premiums and Annuity Revenues	26.86B	30.88B	32.53B	38.63B	43.05B
Total Interest And Dividend Income	52M	143M	404M	453M	420M
Gain (Loss) on Sale of Investments, Total (Rev)	-	-	-10M	-1M	-
Other Revenues, Total	77M	75M	80M	85M	91M
Total Revenues	26.98B	31.1B	33B	39.16B	43.56B
Policy Benefits	23.7B	27.18B	28.67B	34.43B	39.49B
Depreciation & Amortization - (IS) - (Collected)	131M	176M	171M	186M	195M
Selling General & Admin Expenses, Total	1.96B	2.21B	2.34B	2.63B	2.96B
Salaries And Other Employee Benefits	72M	103M	115M	116M	47M
Other Operating Expenses	37M	54M	87M	100M	90M
Total Operating Expenses	25.91B	29.71B	31.38B	37.46B	42.78B
Operating Income	1.08B	1.39B	1.62B	1.71B	784M
Interest Expense, Total	-120M	-110M	-109M	-118M	-192M
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	958M	1.28B	1.51B	1.59B	592M
Restructuring Charges	-	-	-	-	-
Total Merger & Related Restructuring Charges	-34M	-2M	-4M	-1M	-3M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-	-
Asset Writedown	-	-208M	-	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-49M	-4M	-41M	-	-
EBT, Incl. Unusual Items	875M	1.06B	1.46B	1.59B	589M
Income Tax Expense	216M	271M	373M	410M	117M
Earnings From Continuing Operations	659M	792M	1.09B	1.18B	472M
Net Income to Company	659M	792M	1.09B	1.18B	472M
Net Income - (IS)	659M	792M	1.09B	1.18B	472M
Net Income to Common Incl Extra Items	659M	792M	1.09B	1.18B	472M
Net Income to Common Excl. Extra Items	659M	792M	1.09B	1.18B	472M
Per Share Items
Net EPS - Basic	11.4	13.7	18.91	20.54	8.94
Basic EPS - Continuing Operations	11.4	13.7	18.91	20.54	8.94
Basic Weighted Average Shares Outstanding	57.8M	57.8M	57.7M	57.4M	52.8M
Net EPS - Diluted	11.25	13.55	18.77	20.42	8.92
Diluted EPS - Continuing Operations	11.25	13.55	18.77	20.42	8.92
Diluted Weighted Average Shares Outstanding	58.6M	58.5M	58.1M	57.7M	52.9M
Normalized Basic EPS	10.36	13.81	16.35	17.31	7.01
Normalized Diluted EPS	10.22	13.64	16.23	17.22	6.99
Supplemental Items
EBITDA	1.17B	1.51B	1.73B	1.82B	902M
EBITA	1.13B	1.46B	1.7B	1.79B	875M
EBIT	1.08B	1.39B	1.62B	1.71B	784M
EBITDAR	1.2B	1.54B	1.75B	1.84B	914M
Total Revenues (As Reported)	27.77B	31.97B	34.07B	40.65B	45.43B
Effective Tax Rate - (Ratio)	24.69	25.49	25.48	25.8	19.86
Current Domestic Taxes	240M	337M	404M	357M	74M
Current Foreign Taxes	-	-	-	-	-
Total Current Taxes	240M	337M	404M	357M	74M
Deferred Domestic Taxes	-24M	-66M	-31M	53M	43M
Deferred Foreign Taxes	-	-	-	-	-
Total Deferred Taxes	-24M	-66M	-31M	53M	43M
Normalized Net Income	599M	798M	943M	994M	370M
Interest on Long-Term Debt	15M	15M	15M	15M	14M
Supplemental Operating Expense Items
General and Administrative Expenses	1.96B	2.21B	2.34B	2.63B	2.96B
Net Rental Expense, Total	33M	31M	15M	14M	12M
Imputed Operating Lease Interest Expense	12.72M	10.76M	5.19M	4.61M	5.07M
Imputed Operating Lease Depreciation	20.28M	20.24M	9.81M	9.39M	6.93M
Stock-Based Comp., G&A Exp. (Total)	72M	103M	115M	116M	47M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	72M	103M	115M	116M	47M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Total Other Investments	3.2B	3.5B	4.26B	4.32B	4.01B
Total investments	3.2B	3.5B	4.26B	4.32B	4.01B
Cash And Equivalents	4.44B	4.01B	4.85B	4.66B	4.25B
Reinsurance Recoverable - (IS)	-	-	-	-	-
Other Receivables - (Insurance Template)	2.19B	2.34B	3.16B	3.36B	3.58B
Gross Property Plant And Equipment	609M	382M	355M	341M	330M
Accumulated Depreciation	-205M	-213M	-192M	-194M	-194M
Net Property Plant And Equipment	404M	169M	163M	147M	136M
Goodwill	982M	1.12B	1.24B	1.67B	1.96B
Other Intangibles, Total	390M	408M	358M	443M	432M
Other Current Assets, Total	236M	242M	278M	431M	604M
Deferred Tax Assets Long-Term (Collected)	106M	220M	227M	207M	178M
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	263M	318M	361M	389M	416M
Total Assets	12.21B	12.31B	14.89B	15.63B	15.56B
Liabilities
Accounts Payable, Total	792M	826M	1.21B	1.28B	1.04B
Accrued Expenses, Total	2.47B	2.08B	2.29B	1.88B	1.34B
Unpaid Claims	3.36B	3.53B	4.2B	4.64B	4.89B
Unearned Premiums	370M	359M	418M	51M	66M
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	50M	63M	41M	38M	40M
Long-Term Debt	2.17B	2.18B	2.18B	2.92B	3.77B
Long-Term Leases	318M	292M	290M	263M	240M
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	-	-	-	-	-
Deferred Tax Liability Non-Current	-	-	-	-	-
Other Non Current Liabilities	41M	27M	39M	52M	117M
Total Liabilities	9.58B	9.35B	10.68B	11.13B	11.5B
Additional Paid In Capital	236M	328M	410M	462M	452M
Retained Earnings	2.4B	2.8B	3.89B	4.09B	3.6B
Comprehensive Income and Other	-5M	-160M	-82M	-57M	15M
Total Common Equity	2.63B	2.96B	4.22B	4.5B	4.07B
Total Equity	2.63B	2.96B	4.22B	4.5B	4.07B
Total Liabilities And Equity	12.21B	12.31B	14.89B	15.63B	15.56B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	58.4M	57.9M	58.4M	55.5M	51.5M
ECS Total Common Shares Outstanding	58M	58M	58M	56M	51M
Book Value / Share	45.34	51.1	72.67	80.29	79.78
Tangible Book Value	1.26B	1.44B	2.62B	2.38B	1.68B
Tangible Book Value Per Share	21.69	24.84	45.1	42.54	32.92
Total Debt	2.54B	2.53B	2.51B	3.22B	4.05B
Net Debt	-1.9B	-1.48B	-2.34B	-1.44B	-202M
Debt Equivalent Oper. Leases	264M	248M	120M	112M	96M
Account Code - Inventory Valuation	3	3	3	3	3
Land - (BS)	1M	5M	5M	1M	1M
Buildings, Total	37M	41M	41M	35M	38M
Machinery, Total	237M	221M	199M	205M	200M
Full Time Employees	14K	15K	18K	18K	19K

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	659M	792M	1.09B	1.18B	472M
Depreciation, Depletion & Amortization	41M	45M	28M	35M	27M
Amortization of Goodwill and Intangible Assets - (CF)	49M	77M	85M	82M	91M
Total Depreciation, Depletion & Amortization	90M	122M	113M	117M	118M
Amortization of Deferred Charges, Total	41M	54M	58M	69M	77M
(Gain) Loss On Sale of Asset - (CF)	-	-	-	-	-
Total Asset Writedown	-	208M	-	-	-
Restructuring Activities	-	-	-	-	-
Stock-Based Compensation (CF)	72M	103M	115M	116M	47M
Change in Accounts Receivable	-415M	-95M	-778M	-78M	-145M
Change in Accounts Payable	138M	55M	328M	115M	-221M
Change in Unearned Revenues	-5M	-11M	59M	-367M	-51M
Change In Income Taxes	7M	2M	-2M	-18M	-201M
Change in insurance Reserves / Liabilities	471M	153M	580M	-40M	-132M
Change in Other Net Operating Assets (Collected)	1.03B	-552M	127M	-510M	-539M
Other Operating Activities	34M	-58M	-29M	61M	40M
Cash from Operations	2.12B	773M	1.66B	644M	-535M
Capital Expenditure	-77M	-91M	-84M	-100M	-101M
Cash Acquisitions	-129M	-134M	-3M	-344M	-245M
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-1.38B	-515M	-661M	-21M	657M
Other Investing Activities, Total	-63M	-50M	4M	1M	1M
Cash from Investing	-1.65B	-790M	-744M	-464M	312M
Short Term Debt Issued, Total	-	-	-	300M	1.1B
Long-Term Debt Issued, Total	740M	-	-	740M	838M
Total Debt Issued	740M	-	-	1.04B	1.94B
Short Term Debt Repaid, Total	-	-	-	-300M	-1.1B
Long-Term Debt Repaid, Total	-723M	-	-	-	-
Total Debt Repaid	-723M	-	-	-300M	-1.1B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-181M	-454M	-60M	-1.06B	-1.04B
Other Financing Activities, Total	-19M	13M	2M	-30M	29M
Cash from Financing	-183M	-441M	-58M	-347M	-170M
Net Change in Cash	283M	-458M	860M	-167M	-393M
Supplemental Items
Cash Interest Paid	127M	108M	108M	121M	181M
Cash Income Tax Paid (Refund)	235M	340M	405M	379M	275M
Net Debt Issued / Repaid	17M	-	-	740M	838M
Levered Free Cash Flow	886M	329M	864M	510M	-100M
Unlevered Free Cash Flow	961M	398M	932M	584M	20M
Change In Net Working Capital	-161M	657M	281M	686M	611M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.2	7.07	7.43	6.99	3.14
Return on Total Capital	13.88	16.25	16.55	14.78	6.19
Return On Equity %	27.89	28.32	30.39	27.07	11.02
Return on Common Equity	27.89	28.32	30.39	27.07	11.02
Margin Analysis
Gross Profit Margin %	12.16	12.62	13.13	12.09	9.35
SG&A Margin	7.54	7.42	7.45	7	6.9
EBITDA Margin %	4.33	4.85	5.24	4.66	2.07
EBITA Margin %	4.18	4.71	5.16	4.57	2.01
EBIT Margin %	3.99	4.46	4.9	4.36	1.8
Income From Continuing Operations Margin %	2.44	2.55	3.31	3.01	1.08
Net Income Margin %	2.44	2.55	3.31	3.01	1.08
Net Avail. For Common Margin %	2.44	2.55	3.31	3.01	1.08
Normalized Net Income Margin	2.22	2.57	2.86	2.54	0.85
Levered Free Cash Flow Margin	3.28	1.06	2.62	1.3	-0.23
Unlevered Free Cash Flow Margin	3.56	1.28	2.82	1.49	0.05
Asset Turnover
Asset Turnover	2.48	2.54	2.43	2.57	2.79
Fixed Assets Turnover	69.55	108.55	198.81	252.67	307.87
Receivables Turnover (Average Receivables)	-	-	-	-	-
Short Term Liquidity
Current Ratio	1.43	1.47	1.54	1.62	1.69
Quick Ratio	1.39	1.43	1.49	1.56	1.6
Operating Cash Flow to Current Liabilities	0.3	0.11	0.2	0.08	-0.07
Days Sales Outstanding (Average Receivables)	-	-	-	-	-
Average Days Payable Outstanding	57.43	57.14	62.19	60.28	54.79
Long Term Solvency
Total Debt/Equity	96.62	85.39	59.57	71.71	99.43
Total Debt / Total Capital	49.14	46.06	37.33	41.76	49.86
LT Debt/Equity	94.71	83.27	58.6	70.86	98.45
Long-Term Debt / Total Capital	48.17	44.91	36.72	41.27	49.37
Total Liabilities / Total Assets	78.46	75.93	71.7	71.23	73.86
EBIT / Interest Expense	8.98	12.61	14.84	14.47	4.08
EBITDA / Interest Expense	10.01	14	16.02	15.58	4.76
(EBITDA - Capex) / Interest Expense	9.37	13.17	15.25	14.74	4.23
Total Debt / EBITDA	2.12	1.64	1.44	1.75	4.43
Net Debt / EBITDA	-1.58	-0.96	-1.34	-0.78	-0.22
Total Debt / (EBITDA - Capex)	2.26	1.75	1.51	1.85	4.98
Net Debt / (EBITDA - Capex)	-1.69	-1.02	-1.41	-0.83	-0.25
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	46.85	15.26	6.12	18.67	11.23
Gross Profit, 1 Yr. Growth %	28.38	19.7	10.39	9.28	-13.96
EBITDA, 1 Yr. Growth %	16.1	33.07	14.86	5.67	-50.55
EBITA, 1 Yr. Growth %	16.07	33.94	16.48	5.36	-51.09
EBIT, 1 Yr. Growth %	12.76	32.85	16.82	5.82	-54.07
Earnings From Cont. Operations, 1 Yr. Growth %	-2.08	20.18	37.75	8.07	-59.97
Net Income, 1 Yr. Growth %	-2.08	20.18	37.75	8.07	-59.97
Normalized Net Income, 1 Yr. Growth %	12.18	38.2	18.35	5.65	-62.74
Diluted EPS Before Extra, 1 Yr. Growth %	0.18	20.44	38.52	8.79	-56.32
Net Property, Plant and Equip., 1 Yr. Growth %	8.6	-58.17	-3.55	-9.82	-7.48
Accounts Receivable, 1 Yr. Growth %	-	-	-	-	-
Total Assets, 1 Yr. Growth %	28.08	0.86	20.94	4.96	-0.42
Common Equity, 1 Yr. Growth %	25.48	12.7	42.21	6.67	-9.5
Tangible Book Value, 1 Yr. Growth %	18.12	14.55	81.54	-8.94	-29.51
Cash From Operations, 1 Yr. Growth %	11.64	-63.52	115.01	-61.25	-183.07
Capital Expenditures, 1 Yr. Growth %	4.05	18.18	-7.69	19.05	1
Levered Free Cash Flow, 1 Yr. Growth %	-58.06	-61.93	163.55	-40.84	-119.64
Unlevered Free Cash Flow, 1 Yr. Growth %	-55.84	-57.65	135.05	-37.24	-96.57
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	28.51	30.1	10.59	12.22	14.89
Gross Profit, 2 Yr. CAGR %	16.06	23.96	14.95	9.83	-3.03
EBITDA, 2 Yr. CAGR %	3.04	22.84	24.88	10.19	-26.86
EBITA, 2 Yr. CAGR %	3.01	23.17	26.22	10.8	-27.35
EBIT, 2 Yr. CAGR %	1.62	20.83	25.95	11.21	-29.4
Earnings From Cont. Operations, 2 Yr. CAGR %	-5.44	8.48	28.67	22.01	-34.23
Net Income, 2 Yr. CAGR %	-5.44	8.48	28.67	22.01	-34.23
Normalized Net Income, 2 Yr. CAGR %	0.05	22.72	31.32	11.85	-36.41
Diluted EPS Before Extra, 2 Yr. CAGR %	-0.96	9.84	29.17	22.76	-31.06
Net Property, Plant and Equip., 2 Yr. CAGR %	3.11	-32.6	-36.48	-6.74	-8.66
Accounts Receivable, 2 Yr. CAGR %	-	-	-	-	-
Total Assets, 2 Yr. CAGR %	34.12	13.66	10.44	12.66	2.23
Common Equity, 2 Yr. CAGR %	15.84	18.92	26.6	23.16	-1.75
Tangible Book Value, 2 Yr. CAGR %	-14.43	16.32	44.2	28.57	-19.89
Cash From Operations, 2 Yr. CAGR %	120.96	-36.18	-11.44	-8.72	-43.26
Capital Expenditures, 2 Yr. CAGR %	16.23	10.89	4.45	4.83	9.65
Levered Free Cash Flow, 2 Yr. CAGR %	1.58K	-60.49	0.86	25.17	-65.41
Unlevered Free Cash Flow, 2 Yr. CAGR %	308.76	-57.2	0.42	21.68	-85.13
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	14.15	23.93	21.56	13.22	11.89
Gross Profit, 3 Yr. CAGR %	2.94	17.26	19.26	13.03	1.25
EBITDA, 3 Yr. CAGR %	-0.56	11.11	20.07	18.03	-15.65
EBITA, 3 Yr. CAGR %	-0.73	11.29	20.85	18.75	-15.65
EBIT, 3 Yr. CAGR %	-1.59	9.93	19.42	18.75	-17.2
Earnings From Cont. Operations, 3 Yr. CAGR %	-2.32	2.43	17.47	21.4	-15.85
Net Income, 3 Yr. CAGR %	-2.32	2.43	17.47	21.4	-15.85
Normalized Net Income, 3 Yr. CAGR %	-2.1	10.09	21.18	22.03	-22.48
Diluted EPS Before Extra, 3 Yr. CAGR %	1.97	5.71	18.68	21.98	-13.01
Net Property, Plant and Equip., 3 Yr. CAGR %	29.04	-23.67	-24.05	-28.61	-6.99
Accounts Receivable, 3 Yr. CAGR %	-	-	-	-	-
Total Assets, 3 Yr. CAGR %	19.5	21.97	16.04	8.58	8.12
Common Equity, 3 Yr. CAGR %	16.88	14.78	26.22	19.57	11.14
Tangible Book Value, 3 Yr. CAGR %	-3.59	-5.69	34.93	23.71	5.23
Cash From Operations, 3 Yr. CAGR %	88.97	21.22	-4.33	-32.77	-11.54
Capital Expenditures, 3 Yr. CAGR %	36.92	16.88	4.32	9.1	3.54
Levered Free Cash Flow, 3 Yr. CAGR %	17.29	372.25	-25.71	-15.65	-32.52
Unlevered Free Cash Flow, 3 Yr. CAGR %	15.66	90.56	-24.56	-14.22	-62.98
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	9.65	9.85	12.71	19.1	18.84
Gross Profit, 5 Yr. CAGR %	7.85	10.6	7.58	14.23	9.79
EBITDA, 5 Yr. CAGR %	24.98	46.71	7.82	10.66	-2.04
EBITA, 5 Yr. CAGR %	27.23	52.07	8.13	11.01	-1.94
EBIT, 5 Yr. CAGR %	28.64	56.23	7.42	10.35	-3.77
Earnings From Cont. Operations, 5 Yr. CAGR %	66.18	9.12	9.06	9.85	-6.85
Net Income, 5 Yr. CAGR %	66.18	9.12	9.06	9.85	-6.85
Normalized Net Income, 5 Yr. CAGR %	36.12	64.5	8.13	10.69	-6.94
Diluted EPS Before Extra, 5 Yr. CAGR %	65	8.34	12.09	12.23	-4.5
Net Property, Plant and Equip., 5 Yr. CAGR %	8.39	-6.22	-2.81	-17.3	-18.23
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	-
Total Assets, 5 Yr. CAGR %	10.39	7.77	15.79	18.16	10.3
Common Equity, 5 Yr. CAGR %	9.79	17.26	20.68	18.06	14.19
Tangible Book Value, 5 Yr. CAGR %	12.28	8.17	13.25	6.75	9.53
Cash From Operations, 5 Yr. CAGR %	25.78	-0.78	39.55	8.21	-22.37
Capital Expenditures, 5 Yr. CAGR %	-15.24	1.14	22.87	11.9	6.42
Levered Free Cash Flow, 5 Yr. CAGR %	4.11	15.43	9.5	177.01	-45.65
Unlevered Free Cash Flow, 5 Yr. CAGR %	4.9	27.33	8.47	58.96	-60.84